These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34696247)

  • 1. SARS-CoV-2 Neutralizing Antibody Levels Post COVID-19 Vaccination Based on ELISA Method-A Small Real-World Sample Exploration.
    Li X; Liang C; Xiao X
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance evaluation of an automatic chemiluminescence immune platform for SARS-CoV-2 neutralizing antibody after vaccination in real world.
    Li M; Jiang R; Wang E; Xiong D; Ou T; Zhang X; Dou X
    BMC Infect Dis; 2022 Feb; 22(1):157. PubMed ID: 35168557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients.
    Zhang H; Jia Y; Ji Y; Cong X; Liu Y; Yang R; Kong X; Shi Y; Zhu L; Wang Z; Wang W; Fei R; Liu F; Lu F; Chen H; Rao H
    Front Microbiol; 2022; 13():816778. PubMed ID: 35359732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2.
    Hernández-Bello J; Morales-Núñez JJ; Machado-Sulbarán AC; Díaz-Pérez SA; Torres-Hernández PC; Balcázar-Félix P; Gutiérrez-Brito JA; Lomelí-Nieto JA; Muñoz-Valle JF
    Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Anti-SARS-CoV-2 Antibodies Post-Coronavac Vaccination in the Amazon Region of Brazil.
    Bichara CDA; Queiroz MAF; da Silva Graça Amoras E; Vaz GL; Vallinoto IMVC; Bichara CNC; Amaral IPCD; Ishak R; Vallinoto ACR
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model.
    Li C; Chen YX; Liu FF; Lee AC; Zhao Y; Ye ZH; Cai JP; Chu H; Zhang RQ; Chan KH; Chiu KH; Lung DC; Sridhar S; Hung IF; To KK; Zhang AJ; Chan JF; Yuen KY
    Clin Infect Dis; 2021 Aug; 73(3):e719-e734. PubMed ID: 33515458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemiluminescence Immunoassay Based Serological Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Vaccinated Population.
    Yin Q; Zhang Y; Lian L; Qu Y; Wu W; Chen Z; Pei R; Chen T; Sun L; Li C; Li A; Li J; Li D; Wang S; Guan W; Liang M
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
    He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
    Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
    Xia S; Zhang Y; Wang Y; Wang H; Yang Y; Gao GF; Tan W; Wu G; Xu M; Lou Z; Huang W; Xu W; Huang B; Wang H; Wang W; Zhang W; Li N; Xie Z; Ding L; You W; Zhao Y; Yang X; Liu Y; Wang Q; Huang L; Yang Y; Xu G; Luo B; Wang W; Liu P; Guo W; Yang X
    Lancet Infect Dis; 2021 Jan; 21(1):39-51. PubMed ID: 33069281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
    Trougakos IP; Terpos E; Zirou C; Sklirou AD; Apostolakou F; Gumeni S; Charitaki I; Papanagnou ED; Bagratuni T; Liacos CI; Scorilas A; Korompoki E; Papassotiriou I; Kastritis E; Dimopoulos MA
    BMC Med; 2021 Aug; 19(1):208. PubMed ID: 34420521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
    JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of inactivated novel coronavirus vaccine inoculation in patients with chronic hepatitis B].
    Ti YN; Han B; Liu TF; Yuan YJ; Zhang LY
    Zhonghua Gan Zang Bing Za Zhi; 2022 Dec; 30(12):1370-1374. PubMed ID: 36891722
    [No Abstract]   [Full Text] [Related]  

  • 13. SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.
    Suhandynata RT; Bevins NJ; Tran JT; Huang D; Hoffman MA; Lund K; Kelner MJ; McLawhon RW; Gonias SL; Nemazee D; Fitzgerald RL
    J Appl Lab Med; 2021 Sep; 6(5):1109-1122. PubMed ID: 34170314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Antibody Response to the BNT162b2 mRNA Vaccine in Persons with Past Natural Infection.
    Kang YM; Choe KW; Lee KD; Kim KN; Kim MJ; Lim J
    J Korean Med Sci; 2021 Sep; 36(35):e250. PubMed ID: 34490757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The level of protective post-vaccination antibodies in NIPH-NIH employees after administration of Pfizer vaccine against COVID-19.
    Rastawicki W; Płaza K
    Przegl Epidemiol; 2021; 75(1):3-13. PubMed ID: 34328282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia.
    Dispinseri S; Lampasona V; Secchi M; Cara A; Bazzigaluppi E; Negri D; Brigatti C; Pirillo MF; Marzinotto I; Borghi M; Rovere-Querini P; Tresoldi C; Ciceri F; Scavini M; Scarlatti G; Piemonti L
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1472-1481. PubMed ID: 33513242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.
    Zollner A; Watschinger C; Rössler A; Farcet MR; Penner A; Böhm V; Kiechl SJ; Stampfel G; Hintenberger R; Tilg H; Koch R; Antlanger M; Kreil TR; Kimpel J; Moschen AR
    EBioMedicine; 2021 Aug; 70():103539. PubMed ID: 34391087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral Responses to Single-Dose BNT162b2 mRNA Vaccination in Dialysis Patients Previously Infected With SARS-CoV-2.
    Speer C; Morath C; Töllner M; Buylaert M; Göth D; Nusshag C; Kälble F; Schaier M; Grenz J; Kreysing M; Reichel P; Hidmark A; Ponath G; Schnitzler P; Zeier M; Süsal C; Klein K; Benning L
    Front Med (Lausanne); 2021; 8():721286. PubMed ID: 34485347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.